Annual report 2022

3 Segment information

Segment information by business areas

 

 

Healthcare

 

Consumer & Industrial

 

Total medmix

millions of CHF

 

2022

 

2021

 

2022

 

2021

 

2022

 

2021

Revenue 1)

 

184.9

 

169.8

 

292.3

 

287.5

 

477.1

 

457.3

Business area cost of goods sold

 

–72.1

 

–66.6

 

–187.0

 

–170.3

 

–259.1

 

–236.9

Business area gross profit

 

112.7

 

103.2

 

105.3

 

117.1

 

218.0

 

220.4

Business area gross profit margin

 

61.0%

 

60.8%

 

36.0%

 

40.7%

 

45.7%

 

48.2%

1) Revenue from external customers.

Certain expenses are not attributable to a particular business area and are reviewed as a whole across the group irrespective of the business area. These expenses are presented in the following reconciliation statement.

Bridge from business area gross profit to adjusted EBITDA

millions of CHF

 

2022

 

2021

Business area gross profit

 

218.0

 

220.4

Other cost of goods sold

 

–42.6

 

–39.2

Gross profit

 

175.4

 

181.2

Operating expenses

 

–155.8

 

–121.3

Operating income (EBIT)

 

19.6

 

59.9

Depreciation

 

28.8

 

28.7

Amortization

 

20.8

 

22.2

Impairments on tangible and intangible assets

 

1.5

 

0.9

EBITDA

 

70.7

 

111.7

Restructuring expenses

 

1.1

 

0.3

Non-operational items 1)

 

33.6

 

2.5

Adjusted EBITDA

 

105.4

 

114.5

Adjusted EBITDA margin

 

22.1%

 

25.0%

1) Non-operational items include significant acquisition-related expenses, gains and losses from the sale of businesses or real estate (including release of provisions), and certain non-operational items that are non-recurring or do not regularly occur in similar magnitude.

Bridge from cash flow from operating activities to free cash flow

millions of CHF

 

2022

 

2021

 

Cash flow from operating activities

 

47.6

 

87.3

 

Purchase of intangible assets

 

–2.2

 

–2.1

 

Purchase of property, plant and equipment

 

–36.4

 

–29.8

 

Sale of property, plant and equipment

 

1.3

 

0.2

 

Free cash flow (FCF)

 

10.3

 

55.6

 

Information about reportable segments

Operating segments are determined based on the reports reviewed by the Board of Directors (BoD) that are used to measure performance, make strategic decisions, and allocate resources to the segments. The business is managed based on business areas, and the reportable segments have been identified as disclosed below. The BoD assesses the performance of the two segments based on the business areas’ revenue, gross profit and gross profit margin.

The BoD assesses performance of the group using alternative performance measures (APM) that are derived from the financial statements prepared in accordance with IFRS. The APMs are prepared in addition to IFRS to assist in comparability of information across periods by adjusting for depreciation, amortization, impairment, restructuring and other non-operational items (see section alternative performance measures (APM)). In this context, the BoD assesses the performance of the group based on adjusted EBITDA and free cash flow in addition to each business area’s revenue and gross profit.

Revenue from external customers that is reported to the BoD is measured in a manner consistent with that in the income statement. There is no significant revenue between the segments. No individual customer represents a significant portion of the group’s revenue.

Healthcare

Through its well-known brands Haselmeier, Medmix, Mixpac and Transcodent, the Healthcare business area specializes in the design and production of innovative, high-precision delivery devices and services within the drug delivery, surgery and dental markets. Products include injection pens for subcutaneous delivery of drugs, surgical delivery devices focusing on trauma bone repair and wound-healing tissue treatment and mixing, filling and delivery device systems for the dental consumable industry.

The business area’s IP-protected solutions make the customers’ products precise, safe, unique and more sustainable, leveraging the business’s expertise in drug delivery, plastic-injection technology, molding and two-component mixing.

Consumer & Industrial

Through its well-known brands Mixpac, MK, Cox and Geka, the Consumer & Industrial business area specializes in the design and production of innovative, high-precision delivery devices and services within the Industry market segment, such as adhesives used in construction, electronics, automotive, aerospace and various industries and consumer markets such as beauty and other microbrush applications. Products include hand-held mixing and dispensing delivery devices for two-component adhesives and sealants, mixing tips, cartridges, high-precision make-up applicators and microbrushes.

The business area’s IP-protected solutions make the customers’ products precise, safe, unique and more sustainable, leveraging the business’s expertise in plastic injection molding, two-component mixing, fluid handling, material design and microbrushes.

Regional segment information

The allocation of assets is based on their geographical location. Non-current assets exclude non-current financial assets, deferred income tax assets and defined benefit assets. The allocation of revenue from external customers is based on the ship-to location defined by the group’s customer, which does not necessarily correspond with the location of the end customer.

Non-current assets by region

millions of CHF

 

2022

 

2021

Europe, the Middle East and Africa

 

547.7

 

579.4

– thereof Germany

 

319.8

 

339.1

– thereof Switzerland

 

188.8

 

185.3

 

 

 

 

 

Americas

 

48.6

 

35.8

– thereof USA

 

47.0

 

34.2

 

 

 

 

 

Asia-Pacific

 

8.3

 

8.4

– thereof China

 

7.6

 

7.2

 

 

 

 

 

Total non-current assets

 

604.6

 

623.5

Revenue by region

millions of CHF

 

2022

 

2021

Europe, the Middle East and Africa

 

274.9

 

273.2

– thereof Germany

 

98.5

 

106.5

– thereof Italy

 

42.8

 

40.1

– thereof France

 

27.1

 

21.6

– thereof Switzerland

 

23.3

 

18.3

 

 

 

 

 

Americas

 

162.8

 

141.0

– thereof USA

 

143.5

 

129.3

 

 

 

 

 

Asia-Pacific

 

39.4

 

43.1

– thereof China

 

18.6

 

20.6

 

 

 

 

 

Total revenue

 

477.1

 

457.3

Market segment information

The following table shows the allocation of revenue from external customers by market segment:

Revenue by market segment

millions of CHF

 

2022

 

2021

Dental

 

125.1

 

116.3

Drug Delivery

 

47.0

 

40.8

Surgery

 

12.8

 

12.6

Total Healthcare

 

184.9

 

169.8

 

 

 

 

 

Industry

 

148.2

 

160.5

Beauty

 

144.1

 

126.9

Total Consumer & Industrial

 

292.3

 

287.5

 

 

 

 

 

Total revenue

 

477.1

 

457.3